Update on Antiphospholipid Antibody - In-Depth Overview for Physicians
Pregnancy in Autoimmune and Musculoskeletal Disease
Update on Antiphospholipid Antibody
Is it possible for a fetus to develop a fetal intrauterine cerebral infarct (diagnosed after birth by MRI) from an antiphospholipid syndrome (APS) positive mother?
CPC: Catastrophic Antiphospholipid Syndrome Triggered by Sepsis
Antiphospholipid Syndrome (APS): Innovative Treatments Aimed at Improving Lives
CPC: Primary Antiphospholipid Syndrome Presenting as HELLP Syndrome
Lepromatous Leprosy Mimicking Systemic Lupus Erythematosus
When should patients with antiphospholipid antibody be treated with long-term anticoagulation, and how high should the INR be?
An Open Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
A Prospective, Randomized-Controlled Trial Comparing Hydroxychloroquine in the Primary Thrombosis Prophylaxis of Persistently Antiphospholipid Antibody (aPL) Positive but Thrombosis-free Patients without Systemic Autoimmune Diseases.
APS ACTION (Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking) International Clinical Database and Repository.
Comparison of Gut Commensal Bacteria between Persistently Anti-beta2 Glycoprotein-1 Positive Patients and Antiphospholipid Antibody Negative Patients
Effects of Fluvastatin on Proinflammatory and Prothrombotic markers in Antiphospholipid Syndrome
Cognitive Dysfunction, Diffusion Tensor Imaging and Functional Magnetic Resonance Imaging (MRI) in Antiphospholipid Antibody (aPL)-negative Systemic Lupus Erythematosus (SLE) versus aPL-positive non-SLE Patients
Effect of Hydroxychloroquine on the Annexin A5 Resistance Assay in Antiphospholipid Antibody-Positive Patients with and without Systemic Lupus Erythematosus
Autoimmune Disease Registry and Repository
RITAPS: A Pilot Study Of Rituximab For The Anticoagulation-Resistant Manifestations Of Antiphospholipid Syndrome (APS)
PROMISSE: Predictors of Pregnancy Outcome: Biomarkers in Anti-Phospholipid Antibody Syndrome (APS) and Systemic Lupus Erythematosus (SLE)